Does RAMIPRIL Cause Mobility decreased? 1,114 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 1,114 reports of Mobility decreased have been filed in association with RAMIPRIL (Ramipril). This represents 3.4% of all adverse event reports for RAMIPRIL.
1,114
Reports of Mobility decreased with RAMIPRIL
3.4%
of all RAMIPRIL reports
756
Deaths
885
Hospitalizations
How Dangerous Is Mobility decreased From RAMIPRIL?
Of the 1,114 reports, 756 (67.9%) resulted in death, 885 (79.4%) required hospitalization, and 780 (70.0%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RAMIPRIL. However, 1,114 reports have been filed with the FAERS database.
What Other Side Effects Does RAMIPRIL Cause?
Acute kidney injury (3,286)
Dyspnoea (2,537)
Dizziness (2,490)
Hypotension (2,417)
Fatigue (2,415)
Drug ineffective (2,412)
Nausea (2,219)
Vomiting (2,055)
Off label use (2,053)
Hypertension (2,046)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which RAMIPRIL Alternatives Have Lower Mobility decreased Risk?
RAMIPRIL vs RAMUCIRUMAB
RAMIPRIL vs RANEXA
RAMIPRIL vs RANIBIZUMAB
RAMIPRIL vs RANIMUSTINE
RAMIPRIL vs RANITIDINE